Sun Pharmaceutical Industries Q1 Results

  • BSE: 524715
  • NSE: SUNPHARMA
  • ISIN: INE044A01036
  • Sector: Biotechnology & Drugs
BSE
1,9495.00 (0.26%)
Volume4.52 L
Updated: Fri 7 Aug, 2026 | 15:29:01
NSE
1,945-6.00 (-0.31%)
Volume2.43 M
Updated: Fri 7 Aug, 2026 | 15:14:59
Today: 1,925.10
1,956.95
52-Wk: 1,547.25
2,047.55

Q1 Results Highlights

  • Total Income
    ₹15,299.88 Cr.
    (10.46%)
  • Operating Profit
    ₹3,352.87 Cr.
    (31.28%)
  • Profit After Tax
    ₹2,885.36 Cr.
    (32.47%)
  • Operating Margin
    21.91%
    (18.85%)
Note: Comparison is on YoY basis

Quarterly - Sun Pharmaceutical Industries Q1 Results

*All figures in crores except per share values
Fiscal PeriodJun 26Mar 26QoQ CompJun 24YoY Comp
Total Operating Expense 11,947.0111,859.810.74%9,649.815.75%
Depreciation/ Amortization 738.72775.47-4.74%655.135.45%
Operating Income 3,352.872,751.9821.83%3,002.9431.28%
Net Income 2,894.792,714.036.66%2,835.6227.04%
Other Operating Expenses Total 4,813.815,322.84-9.56%3,864.6315.65%
Net Income Before Taxes 4,098.813,551.3415.42%3,423.5029.19%
Total Revenue 15,299.8814,611.794.71%12,652.7510.46%
Selling/ General/ Admin Expenses Total 3,227.232,960.419.01%2,454.6215.19%
Diluted Normalized EPS 12.6611.5010.17%11.8010.63%
Recommended For You

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe

      Trending Now In Market